![What do you think of this newspaper advertisement for Stem Cells?]()
by Admin | Jan 15, 2019 | News & Opinions
Who owns the brand “stem cells” ? Lofty scientific societies, such as the International Society for Stem Cell Research (ISSCR)? How about medical associations like the American Society for Plastic Surgeons (ASPS) or members of the International Federation...
![What do you think of this newspaper advertisement for Stem Cells?]()
by admin | Jan 15, 2019 | News & Opinions
How profound is the coming age of cell and gene therapies? Answered simply, it will profoundly impact medicine and humanity. Converging “Future Shock” technologies. Societal change. How big? Think the Industrial Revolution- the Bronze Age- the discovery of...
![What do you think of this newspaper advertisement for Stem Cells?]()
by admin | Jan 14, 2019 | News & Opinions
Accomplish your goals at World Stem Cell Summit & Phacilitate Leaders World, Jan. 22-25, Miami! Dear Colleague, With 2,000 attendees from 40 nations, the 14th World Stem Cell Summit and award-winning Phacilitate Leaders World conferences in Miami, Florida will...
by Admin | Jan 10, 2019 | News & Opinions
MIAMI – May 23, 2018 – Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for age-related diseases, announced that it is currently recruiting for a Phase 1 clinical trial to evaluate the safety and efficacy of its allogeneic Mesenchymal Stem...
by Admin | Jan 10, 2019 | News & Opinions
Grant will be applied to Longeveron’s Aging Frailty stem cell research MIAMI, Oct. 18, 2018 – Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that the company has been awarded a $3.8 million Small...
by Bernard Siegel | Jan 8, 2019 | News & Opinions
Miami, Fla. – Jan. 7, 2019 – The Regenerative Medicine Manufacturing Society (RMMS) returns to the Phacilitate Leaders World and World Stem Cell Summit for its second annual membership meeting to be held on the pre-conference day in Miami, Fl. The meeting, which will...
